Tech Company Inital Public Offerings
Zosano Pharma IPO
On 1/28/2015, Zosano Pharma became a public company.
Transaction Overview
Company Name
Announced On
1/28/2015
Transaction Type
IPO
Amount
$49,500,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
34790 Ardentech Ct.
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Overview
Zosamo Pharma (NASDAQ: ZSAN) is a specialty pharmaceutical company focused on the development of novel proprietary products via the Macroflux technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Walker
Chief Financial Officer
Gregory Kitchener
Chief Medical Officer
Donald Kellerman
VP - Operations
Hayley Lewis
Browse more venture capital transactions:
Prev: 1/28/2015: FinalCard venture capital transaction
Next: 1/28/2015: Crossover Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs